Exposure to aminoglycosides should be monitored during treatment

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7055.491 (Published 24 August 1996) Cite this as: BMJ 1996;313:491
  1. Evan J Begg, Clinical pharmacologist,
  2. Stephen B Duffull, Drug information pharmacist,
  3. Carl M Kirlpatrick, Drug information pharmacist
  1. Department of Clinical Pharmacology, Christchurch Hospital, PO Box 4710, Christchurch, New Zealand

    EDITOR,—In her commentary on Michael Barza and colleagues' meta-analysis of whether aminoglycosides should be given in single or multiple daily doses, Fiona Smaill advocates once daily dosing.1 We agree with her but believe that her recommendation not to monitor aminoglycoside concentrations routinely is ill conceived. Opinion on this …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription